4/8
08:42 am
iron
Rating for IRON
Medium
Report
Rating for IRON
4/2
02:01 pm
iron
Rating for IRON
Low
Report
Rating for IRON
4/2
02:01 pm
iron
Rating for IRON
Low
Report
Rating for IRON
4/2
12:13 pm
iron
Rating for IRON
Medium
Report
Rating for IRON
4/2
12:13 pm
iron
Rating for IRON
Medium
Report
Rating for IRON
4/2
09:00 am
iron
Rating for IRON
Medium
Report
Rating for IRON
4/1
01:22 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $43.00 price target on the stock, down previously from $84.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $43.00 price target on the stock, down previously from $84.00.
4/1
01:22 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $43.00 price target on the stock, down previously from $84.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $43.00 price target on the stock, down previously from $84.00.
4/1
11:03 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $40.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $40.00 price target on the stock.
4/1
11:03 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $40.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $40.00 price target on the stock.
4/1
10:37 am
iron
Rating for IRON
High
Report
Rating for IRON
4/1
10:37 am
iron
Rating for IRON
High
Report
Rating for IRON
4/1
10:15 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
High
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
3/22
11:19 am
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
3/21
11:09 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock, up previously from $79.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock, up previously from $79.00.
3/21
11:09 pm
iron
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock, up previously from $79.00.
Medium
Report
Disc Medicine, Inc. (NASDAQ: IRON) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock, up previously from $79.00.
3/12
09:26 am
iron
Rating for IRON
Low
Report
Rating for IRON
2/29
08:05 am
iron
Rating for IRON
Medium
Report
Rating for IRON
2/29
08:05 am
iron
Rating for IRON
Medium
Report
Rating for IRON